News & Updates

Antibiotics reduce efficacy of immune checkpoint inhibitors

03 Jun 2021

Use of antibiotics during immune checkpoint blockade (ICB) has a significantly negative impact on the efficacy of immunotherapy, reveals a study. The greatest negative impact occurs when using antibiotics in the first 6 weeks after initiating ICB.

Antibiotics reduce efficacy of immune checkpoint inhibitors

03 Jun 2021

Singapore women weigh in on postpartum glucose tolerance testing

03 Jun 2021 by

Women remain reluctant to undergo a postpartum oral glucose tolerance test (OGTT) despite universal education regarding gestational diabetes mellitus (GDM), according to a recent Singapore study. Those who received specific recommendations from their prenatal care providers were much more likely to take a postpartum OGTT.

Singapore women weigh in on postpartum glucose tolerance testing

03 Jun 2021

Internet-delivered CBT effective for youths with social anxiety disorder

03 Jun 2021

A 10-week course of internet-delivered cognitive behavioural therapy (ICBT) is an efficacious and cost-effective intervention for children and adolescents with social anxiety disorder (SAD) compared with internet-delivered supportive therapy (ISUPPORT), results of a recent randomized clinical study have shown.

Internet-delivered CBT effective for youths with social anxiety disorder

03 Jun 2021

Mental health recovery slow during COVID-19 pandemic

03 Jun 2021

Mental health of most adults in the UK remained resilient or returned to around the same level prior to the coronavirus disease 2019 (COVID-19) pandemic, although around one in nine had deteriorating or consistently poor mental health, results of a recent latent class trajectory analysis have shown.

Mental health recovery slow during COVID-19 pandemic

03 Jun 2021

Fenebrutinib disappoints in systemic lupus erythematosus

03 Jun 2021

The noncovalent, highly selective inhibitor of Bruton’s tyrosine kinase fenebrutinib is safe in patients with systemic lupus erythematosus but falls short of improving disease activity, according to the results of a phase II trial.

Fenebrutinib disappoints in systemic lupus erythematosus

03 Jun 2021

C. difficile infection may lead to irritable bowel syndrome for some patients

03 Jun 2021

About 20 percent of patients develop postinfection irritable bowel syndrome after Clostridioides difficile infection, according to a study.

C. difficile infection may lead to irritable bowel syndrome for some patients

03 Jun 2021

Copanlisib-rituximab combo extends PFS in relapsed indolent non-Hodgkin lymphoma

02 Jun 2021 by

The combination of copanlisib and rituximab extended progression-free survival (PFS) compared with rituximab alone in patients with relapsed indolent non-Hodgkin lymphoma, results of the phase III CHRONOS-3 trial showed.

Copanlisib-rituximab combo extends PFS in relapsed indolent non-Hodgkin lymphoma

02 Jun 2021

GLP-1RAs help improve blood glucose control, but have differing effects on body weight

02 Jun 2021

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) help improve glycated haemoglobin levels in patients with type 2 diabetes, though different drugs work through different mechanisms of action, particularly in terms of lowering body weight, a new study has found.

GLP-1RAs help improve blood glucose control, but have differing effects on body weight

02 Jun 2021

4-month rifapentine regimen on par with 6-month standard TB care

02 Jun 2021 by

A shorter treatment course of 4 months with a rifapentine-based regimen containing moxifloxacin proves to be noninferior to a standard 6-month regimen in patients with drug-susceptible tuberculosis, a phase III randomized trial has shown.

4-month rifapentine regimen on par with 6-month standard TB care

02 Jun 2021

Diazepam nasal spray safe to use with benzodiazepine

02 Jun 2021 by

For patients with epilepsy, diazepam nasal spray is safe regardless of concomitant benzodiazepine use, according to the results of a phase III, open-label safety study.

Diazepam nasal spray safe to use with benzodiazepine

02 Jun 2021

News & Updates

Filter by Specialty:

Specialty:

Antibiotics reduce efficacy of immune checkpoint inhibitors

Antibiotics reduce efficacy of immune checkpoint inhibitors

Singapore women weigh in on postpartum glucose tolerance testing

Singapore women weigh in on postpartum glucose tolerance testing

Internet-delivered CBT effective for youths with social anxiety disorder

Internet-delivered CBT effective for youths with social anxiety disorder

Mental health recovery slow during COVID-19 pandemic

Mental health recovery slow during COVID-19 pandemic

Fenebrutinib disappoints in systemic lupus erythematosus

Fenebrutinib disappoints in systemic lupus erythematosus

C. difficile infection may lead to irritable bowel syndrome for some patients

C. difficile infection may lead to irritable bowel syndrome for some patients

Copanlisib-rituximab combo extends PFS in relapsed indolent non-Hodgkin lymphoma

Copanlisib-rituximab combo extends PFS in relapsed indolent non-Hodgkin lymphoma

GLP-1RAs help improve blood glucose control, but have differing effects on body weight

GLP-1RAs help improve blood glucose control, but have differing effects on body weight

4-month rifapentine regimen on par with 6-month standard TB care

4-month rifapentine regimen on par with 6-month standard TB care

Diazepam nasal spray safe to use with benzodiazepine

Diazepam nasal spray safe to use with benzodiazepine